Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Helius Medical Technologies Inc | HSDT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 5.82 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.82 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 4.29 - 14.44 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 5.82 | USD |
Helius Medical Technologies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.12M | 708.25k | - | 787k | -14.07M | -19.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Helius Medical Technolog... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HSDT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.13 | 6.50 | 5.73 | 5.97 | 33,413 | -0.31 | -5.06% |
| 1 Month | 5.85 | 7.188 | 5.50 | 6.43 | 333,871 | -0.03 | -0.51% |
| 3 Months | 7.00 | 9.50 | 4.29 | 6.21 | 438,214 | -1.18 | -16.86% |
| 6 Months | 7.72 | 9.50 | 4.29 | 6.24 | 208,913 | -1.90 | -24.61% |
| 1 Year | 10.00 | 14.44 | 4.29 | 8.32 | 376,369 | -4.18 | -41.80% |
| 3 Years | 869.50 | 893.50 | 4.29 | 39.73 | 691,221 | -863.68 | -99.33% |
| 5 Years | 4,060.00 | 5,792.50 | 4.29 | 346.93 | 561,490 | -4,054.18 | -99.86% |
Helius Medical Technolog... Description
| Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources. |
